Results 81 to 90 of about 14,691 (187)

腹腔镜下腹膜透析置管术后远期合并腹壁渗漏一例

open access: yesLinchuang shenzangbing zazhi, 2017
患者女,45岁,2014年10月6日因"反复浮肿6年,维持性腹膜透析10+月,腹透超滤减少4天"入院。患者6年前因水肿发现肾功能异常,2013年3月20日患者行右腕部内瘘术开始维持性血液透析治疗;2014年1月5日因内瘘血流量差停血液透析,腹腔镜下行腹膜透(peritoneal dialysis,PD)析置管,术后转为PD治疗 ...
高芳, 王少清, 周萍
doaj  

[Advances in pharmacological research for retinopathy of prematurity]. [PDF]

open access: yesZhejiang Da Xue Xue Bao Yi Xue Ban
Xie Y, Zheng S, Yang H.
europepmc   +1 more source

[Clinical characteristics and outcomes of 11 neonates with venous thrombosis]. [PDF]

open access: yesZhongguo Dang Dai Er Ke Za Zhi
Gu XG   +4 more
europepmc   +1 more source

[Frontier progress in complex wound repair: from microenvironment regulation to precision medical practice]. [PDF]

open access: yesZhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
Hu DH, Li MY, Wang P.
europepmc   +1 more source

[Dural arteriovenous fistula in a neonate presenting with respiratory distress]. [PDF]

open access: yesZhongguo Dang Dai Er Ke Za Zhi
DU Y, Zhang JH, Li JL, Wang ZP, Wu MG.
europepmc   +1 more source

经导管肝动脉化疗栓塞术治疗肝癌

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1990
1986年12月~1989年2月采用经导管肝动脉化疗栓塞术治疗肝癌60例。全部病例均经股动脉穿刺插管,行腹腔动脉、肠系膜上动脉造影后将导管送入肝癌之供血动脉,注入阿霉素及氟脲嘧啶、碘油乳浊液。术后1个月内死于并发症8例,其余存活1个月以上,最长存活26个月仍健在。以寿命表法统计半年、1年、2年的累计受治存活率分别为63.0%、36.0%、24.0%。本文根据60例治疗体会及治疗效果,讨论了本疗法术前诊断及术后观察、治疗肝癌的估计、栓塞药物的选择、栓塞后的并发症等。
doaj  

[Guideline for transfusion management in Chinese children with transfusion-dependent thalassemia (2025)]. [PDF]

open access: yesZhongguo Dang Dai Er Ke Za Zhi
Committee of Thalassemia Prevention and Treatment   +6 more
europepmc   +1 more source

[Treatment strategy for severe radiation-induced ulcers near major blood vessels]. [PDF]

open access: yesZhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
Cao TY   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy